The Riverside closure underscores a hard truth: resilience is not free. Maintaining onshore or near-shore manufacturing ...

A rendering of the $5 billion manufacturing facility that Eli LIlly plans to build in Virginia's Goochland County near Richmond. The planned manufacturing plant will be the company's first-ever ...

Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing facility at Generation Park in Houston, in the US state of Texas. The new ...

AbbVie (ABBV) announced the start of construction of its new active pharmaceutical ingredient manufacturing plant in North Chicago, Illinois. This is a significant milestone in AbbVie’s ongoing ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...

German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest manufacturing sites for DNA- and RNA-based active pharmaceutical ingredients (API). The ...

AstraZeneca has broken ground on a $4.5 billion manufacturing facility near Charlottesville, Virginia, confirming a report about its location six weeks ago when state lawmakers approved an economic ...